| DNTH Market Cap History Table | ||||||||||||||||||||||
Below is a table of the DNTH market cap history going back to 7/31/2023:
Also see: DNTH Shares Outstanding History and DNTH YTD Return |
As of 5/1/2026 Dianthus Therapeutics has a market cap of 4.78 billion. Investors often follow the DNTH market cap history to compare the size of the company over time.
This page shows DNTH market capitalization trends over time, with 10 market cap datapoints presented, dating back to 7/31/2023.

| DNTH Market Cap History Table | ||||||||||||||||||||||
Below is a table of the DNTH market cap history going back to 7/31/2023:
Also see: DNTH Shares Outstanding History and DNTH YTD Return |
| DNTH Market Cap History Chart | ||||||||||||||||||||||||||||||
DNTH Historical Market Cap: +429.59% CAGR
Mouse over chart for data details
| ||||||||||||||||||||||||||||||
| DNTH Stock Price Chart |
| About Dianthus Therapeutics Inc |
| Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to advancing antibody complement therapeutics to treat severe autoimmune diseases. Co. is dedicated to designing and delivering monoclonal antibodies with improved selectivity and potency. Co. has initiated a Phase 2 trial of DNTH103, a potential active C1s inhibitor, in generalized Myasthenia Gravis and plans to initiate additional Phase 2 trials in other neuromuscular indications, including Multifocal Motor Neuropathy and Chronic Inflammatory Demyelinating Polyneuropathy. We show 10 historical shares outstanding datapoints in our DNTH shares outstanding history coverage, used to compute DNTH market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DNTH market cap history over the course of time is important for investors interested in comparing DNTH's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DNTH versus a peer is one thing; comparing DNTH market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DNTH can fluctuate over the course of history. With this page we aim to empower investors researching DNTH by allowing them to research the DNTH market cap history. |
| DNTH Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| DNTH Share Performance |
| Market Cap Peers |
| Dianthus Therapeutics (DNTH) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
DOMH Market Cap History DOVA Market Cap History DPLO Market Cap History DRAD Market Cap History DRIO Market Cap History DRMA Market Cap History DRNA Market Cap History DRRX Market Cap History DSGN Market Cap History DTIL Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.